ClinicalTrials.gg
CompletedNCT02687633Updated Jul 23, 2026

Early Behavioral Intervention to Improve Social Communication Function in Infants With Tuberous Sclerosis Complex

An interventional study of JASPER in Tuberous Sclerosis Complex, sponsored by University of California, Los Angeles. Completed at 1 site in United States. Open to participants aged 12 Months to 36 Months. Per ClinicalTrials.gov, last updated 2026-07-23.

Sponsored by University of California, Los Angeles · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
8
Allocation
Randomized
Ages
12 Months to 36 Months
Sex
All
01

Study summary

The investigators are running an intervention study for young children with Tuberous Sclerosis Complex (TSC). The study will include free play-based behavioral intervention that may improve social and communication skills in children with TSC. Eligible families will have a child in the age range of 12-36 months, with a diagnosis of TSC. A parent must also be available to attend the weekly intervention sessions at UCLA.

The intervention will focus on teaching caregivers skills to improve the social and communication outcomes of their children. The content of the intervention will be individually tailored to the child's developmental level. The intervention involves pre-assessments, an intervention period of daily 60 minute sessions for 10 days, followed by weekly 60 minute sessions for 10 weeks, and post-assessments. The classroom can have up to 3 parent-child dyad and the curriculum focuses on improving social-communication and play skills.

Read the detailed description

Most children with Tuberous Sclerosis Complex (TSC) suffer from neurodevelopmental disabilities, including intellectual disability (ID) and autism spectrum disorder (ASD). There is a tremendous need for early intervention for all infants with TSC, with a focus on improving non-verbal cognition and social communication skills. However, no studies have investigated whether early intervention can improve social communication skills in infants with TSC. As a result, families of infants with TSC struggle to receive adequate interventions targeting these areas of development.

The investigators propose to enroll 32 infants and toddlers with TSC to study an evidence-based behavioral intervention in infants with TSC, combining the efforts of investigators with expertise in autism intervention, infant development, and TSC. The proposed intervention study adapts a parent-mediated treatment called JASPER (Joint attention, symbolic play, engagement, regulation) that has successfully improved social communication outcomes in toddlers and young children with ASD.

JASPER intervention will last 3 months, and is split into two phases. Phase 1 occurs for the first 2 weeks of intervention, and consists of daily 1 hour intervention sessions (Monday through Friday) for 2 weeks. After Phase 1, Phase two begins, and consists of 60 minute sessions once a week for 10 weeks. Participants will receive behavioral assessments and EEG across 4 assessment time points during this study: At the start of participation in the study, two weeks into participation of the study, 3 months into participation of the study, and 6 months into participation in the study. The behavioral assessments administered throughout these time points will measure social communication skills, overall cognitive functioning, and non-verbal communication. EEG is sensitive to subtle changes in the brain and may be able to capture responses to treatment prior to clinical or behavioral change, and can inform researchers of the brain basis for the behavioral changes found with intervention. The EEG at each time point will be 30-45 minutes in length, and will require the participant to be awake, as they will watch several short videos on a tv screen while recording EEG data.

There are 2 randomized participation groups in this study, Treatment Group 1, and Treatment Group 2. Treatment group 1 will begin JASPER intervention immediately, and thus will complete the first 3 assessment time points while in intervention, and the 4th assessment time point 3 months after intervention ends. Treatment Group 2 will complete the 4 assessment time points while receiving services as usual in the community, and will begin intervention after the 4th assessment time point. Treatment group 1 will participate in this study for a total of 6 months, and treatment group 2 will participate in the study for a total of 9 months, since they will receive services in the community as usual for 6 months before beginning the 3 month intervention. Group assignment is randomized, and each participant has an equal chance of being assigned to either treatment group.

02

Conditions studied

  • Tuberous Sclerosis Complex

Browse trials for

03

In context

Tuberous Sclerosis

115 studies on the registry are indexed under Tuberous Sclerosis; 27 are open to participants now.

This study's enrollment of 8 is below the median of 52 across 73 interventional studies indexed under Tuberous Sclerosis.

Browse Tuberous Sclerosis studies →

Lead sponsor

University of California, Los Angeles is the lead sponsor of 1,170 studies on the registry; 195 are open to participants now.

Of its 95 completed or terminated interventional studies of FDA-regulated products, 70 (74%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
12 Months to 36 Months
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • A confirmed diagnosis of Tuberous Sclerosis Complex

Exclusion criteria

Exclusion Criteria:

  • A mental age less than 6 months. A plan for epilepsy surgery during the study participation period.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
8 participants (actual)

Study arms

  • Experimental
    Treatment Group

    The Treatment Group begins the JASPER intervention immediately upon enrollment in the study.

    Behavioral: JASPER

  • Active comparator
    Delayed Treatment Group

    The Delayed treatment group receives the same JASPER intervention as the Treatment Group, but after 6 months of receiving services in the community as usual.

    Behavioral: JASPER

Interventions

  • BehavioralJASPER

    JASPER (Joint Attention, Symbolic Play, Engagement, and Regulation) is a treatment approach based on a combination of developmental and behavioral principles developed by Dr. Connie Kasari and Dr. Amanda Gulsrud at UCLA. It targets the foundations of social communication (joint attention, imitation, play) and uses naturalistic strategies to increase the rate and complexity of social communication.

    Also known as: Joint Attention, Symbolic Play and Engagement Regulation

06

What researchers measure

Primary outcomes

  1. change from baseline in Joint Engagement (shared engagement in a play routine) at 2 weeks into study participation, according to the parent caregiver interaction assessment.

    Parent Caregiver Interaction assesses the amount of time the parent and child spend in engaged in the same play routine.

    Time frame: 2 weeks

  2. change from baseline in Joint Engagement (shared engagement in a play routine) at 3 months into study participation, according to the parent caregiver interaction assessment.

    Parent Caregiver Interaction assesses the amount of time the parent and child spend in engaged in the same play routine.

    Time frame: 3 months

  3. change from baseline in Joint Engagement (shared engagement in a play routine) at 6 months into study participation, according to the parent caregiver interaction assessment.

    Parent Caregiver Interaction assesses the amount of time the parent and child spend in engaged in the same play routine.

    Time frame: 6 months

Secondary outcomes

  1. Change from baseline in the amount of time spent in a Joint Attention (the coordination of attention between objects and people for the purpose of sharing) state at 2 weeks

    ESCS (Early Social Communication Scales) Assessment.

    Time frame: 2 weeks

  2. Change from baseline in the amount of time spent in a Joint Attention (the coordination of attention between objects and people for the purpose of sharing) state at 3 months

    ESCS (Early Social Communication Scales) Assessment.

    Time frame: 3 months

  3. Change from baseline in the amount of time spent in a Joint Attention (the coordination of attention between objects and people for the purpose of sharing) state at 6 months

    ESCS (Early Social Communication Scales) Assessment.

    Time frame: 6 months

  4. Change from baseline in Symbolic Play (types of play and level of play) at 2 weeks, according to the Structured Play Assessment (SPA)

    The Structured Play Assessment measures the child's play level, based on distinct sets of toys that target specific developmental markers of play.

    Time frame: 2 weeks

  5. Change from baseline in Symbolic Play (types of play and level of play) at 3 months, according to the Structured Play Assessment (SPA)

    The Structured Play Assessment measures the child's play level, based on distinct sets of toys that target specific developmental markers of play.

    Time frame: 3 months

  6. Change from baseline in Symbolic Play (types of play and level of play) at 6 months, according to the Structured Play Assessment (SPA)

    The Structured Play Assessment measures the child's play level, based on distinct sets of toys that target specific developmental markers of play.

    Time frame: 6 months

  7. Change from baseline at 3 months in developmental quotient, as determined by the Mullen Scales of Early Learning

    Cognition will be determined by a Developmental Quotient on a traditional cognitive measure, the Mullen Scales of Early Learning

    Time frame: 3 months

  8. Change from baseline at 6 months in developmental quotient, as determined by the Mullen Scales of Early Learning

    Cognition will be determined by a Developmental Quotient on a traditional cognitive measure, the Mullen Scales of Early Learning

    Time frame: 6 months

  9. Change from baseline at 2 weeks in the amount of Parent use of social communication support strategies

    Parent use of social communication support strategies as taught by JASPER will be measured by a parent-child interaction assessment.

    Time frame: 2 weeks

  10. Change from baseline at 3 months in the amount of Parent use of social communication support strategies

    Parent use of social communication support strategies as taught by JASPER will be measured by a parent-child interaction assessment.

    Time frame: 3 months

  11. Change from baseline at 6 months in the amount of Parent use of social communication support strategies

    Parent use of social communication support strategies as taught by JASPER will be measured by a parent-child interaction assessment.

    Time frame: 6 months

07

Study locations

1 site
  • UCLA Semel Insitute
    Los Angeles, California 90095, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 23, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02687633
Responsible party
Sponsor
First posted
Feb 22, 2016
Start date
Sep 2015
Primary completion
Aug 2017
Completion
Aug 2017
Last update
Jul 23, 2026

Study contacts

Shafali Jeste, MD
principal investigator · University of California, Los Angeles

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion